Sagar Pradeep, Sodhi Preetkanwar Singh, Roy Sangeeta, Takkar Brijesh, Azad Shorya Vardhan
Department of Vitreo-Retina, Sankara Eye Hospital, Shivamogga, India.
Department of Vitreo Retina, Sodhi Eye Hospital, Patiala, India.
Eur J Ophthalmol. 2021 Jul 29:11206721211036290. doi: 10.1177/11206721211036290.
There have been major changes in our understanding of choroidal diseases in the last decade owing to multiple retinal and choroidal imaging related advances. A major conceptual pivot is establishment of pachychoroid and its spectrum of clinical disorders: pachychoroid pigment epitheliopathy, central serous chorioretinopathy, pachychoroid neovasculopathy, polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization, peripapillary pachychoroid syndrome, and focal choroidal excavation. However, considerable overlaps in manifestations and therapeutics of these disorders make differentiation amongst them difficult. This review is focused on pathogenesis and clinical aspects of pachychoroid neovasculopathy (PNV). Since PNV was defined as a separate entity around 5 years ago, there have been numerous contrasting observations surrounding it. We review and summarize these studies, and also compare PNV with other disorders of the pachychoroid spectrum in detail. There are important differences between etiologies of neovascular age related macular degeneration and PNV. Yet the current treatment strategies for PNV have been extrapolated from the trials for the former. Future research needs to validate this assumption with long-term results.
在过去十年中,由于视网膜和脉络膜成像技术的多项进展,我们对脉络膜疾病的认识发生了重大变化。一个主要的概念转变是厚脉络膜及其一系列临床病症的确立:厚脉络膜色素上皮病变、中心性浆液性脉络膜视网膜病变、厚脉络膜新生血管病变、息肉样脉络膜血管病变/1型动脉瘤样新生血管、视盘周围厚脉络膜综合征和局限性脉络膜凹陷。然而,这些病症在临床表现和治疗方法上存在相当大的重叠,使得它们之间的鉴别诊断具有挑战性。本综述聚焦于厚脉络膜新生血管病变(PNV)的发病机制和临床方面。自从PNV在大约5年前被定义为一个独立的实体以来,围绕它出现了许多相互矛盾的观察结果。我们回顾并总结这些研究,并详细比较PNV与厚脉络膜谱系中的其他病症。新生血管性年龄相关性黄斑变性和PNV的病因存在重要差异。然而,目前PNV的治疗策略是从前者的试验中推断出来的。未来的研究需要通过长期结果来验证这一假设。